Literature DB >> 8563457

Observations on midodrine in a case of vasodepressor neurogenic syncope.

C Ward1, R A Kenny.   

Abstract

A 43-year-old man presented with recurrent syncope and dizziness after he had a dual chamber pacemaker fitted for presumed sino-atrial disease. Head-up tilt produced vasodepressor neurocardiogenic syncope, despite appropriate heart rate support during pacing, and reproduced symptoms. Symptoms were not improved by disopyramide. A double-blind cross-over trial of midodrine, an alpha-receptor agonist, was effective in reducing symptoms: it abolished syncope and reduced frequency and severity of dizziness, coupled with improved haemodynamic responses to head-up tilt.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8563457     DOI: 10.1007/bf01818889

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  23 in total

Review 1.  Malignant vasovagal syncope: prolonged asystole provoked by head-up tilt. Case report and review of diagnosis, pathophysiology, and therapy.

Authors:  J D Maloney; F J Jaeger; F M Fouad-Tarazi; H H Morris
Journal:  Cleve Clin J Med       Date:  1988 Nov-Dec       Impact factor: 2.321

2.  Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine).

Authors:  H Kaufmann; T Brannan; L Krakoff; M D Yahr; J Mandeli
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

3.  Circulatory control mechanisms in vasodepressor syncope.

Authors:  D S Goldstein; M Spanarkel; A Pitterman; R Toltzis; E Gratz; S Epstein; H R Keiser
Journal:  Am Heart J       Date:  1982-11       Impact factor: 4.749

4.  Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome.

Authors:  B P Grubb; P Temesy-Armos; J Moore; D Wolfe; H Hahn; L Elliot
Journal:  Am J Cardiol       Date:  1992-04-01       Impact factor: 2.778

5.  Lack of variation in venous tone potentiates vasovagal syncope.

Authors:  A D Hargreaves; A L Muir
Journal:  Br Heart J       Date:  1992-06

6.  Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing.

Authors:  J S Sra; A J Anderson; S H Sheikh; B Avitall; P J Tchou; P J Troup; C J Gilbert; M Akhtar; M R Jazayeri
Journal:  Ann Intern Med       Date:  1991-06-15       Impact factor: 25.391

7.  Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.

Authors:  A Schirger; S G Sheps; J E Thomas; R D Fealey
Journal:  Mayo Clin Proc       Date:  1981-07       Impact factor: 7.616

8.  Vasovagal reactions may occur after orthotopic heart transplantation.

Authors:  A P Fitzpatrick; N Banner; A Cheng; M Yacoub; R Sutton
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

9.  Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test.

Authors:  W N Kapoor; N Brant
Journal:  Ann Intern Med       Date:  1992-03-01       Impact factor: 25.391

10.  The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin.

Authors:  F Abi-Samra; J D Maloney; F M Fouad-Tarazi; L W Castle
Journal:  Pacing Clin Electrophysiol       Date:  1988-08       Impact factor: 1.976

View more
  5 in total

1.  Fludrocortisone in the treatment of hypotensive disorders in the elderly.

Authors:  R M Hussain; S J McIntosh; J Lawson; R A Kenny
Journal:  Heart       Date:  1996-12       Impact factor: 5.994

2.  Role of carotid sinus syndrome and neurocardiogenic syncope in recurrent syncope and falls in patients referred to an outpatient clinic in a district general hospital.

Authors:  A Eltrafi; D King; J H Silas; P Currie; M Lye
Journal:  Postgrad Med J       Date:  2000-07       Impact factor: 2.401

3.  Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope.

Authors:  B P Grubb; B Karas; D Kosinski; K Boehm
Journal:  J Interv Card Electrophysiol       Date:  1999-07       Impact factor: 1.900

4.  Midodrine: a role in the management of neurocardiogenic syncope.

Authors:  C R Ward; J C Gray; J J Gilroy; R A Kenny
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

5.  Syncope.

Authors:  Pamela Nerheim; Brian Olshansky
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.